Bora Pharmaceuticals Co., Ltd. (TPE:6472)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
490.00
-53.00 (-9.76%)
At close: Feb 11, 2026
Market Cap60.77B -25.8%
Revenue (ttm)21.10B +36.0%
Net Income3.08B -24.4%
EPS24.04 -22.3%
Shares Out124.02M
PE Ratio15.03
Forward PE12.65
Dividend11.67 (2.38%)
Ex-Dividend DateJun 20, 2025
Volume4,107,775
Average Volume1,986,610
Open501.00
Previous Close543.00
Day's Range489.00 - 509.00
52-Week Range468.42 - 795.00
Beta0.81
RSI36.62
Earnings DateMar 5, 2026

About Bora Pharmaceuticals

Bora Pharmaceuticals Co., Ltd. engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally. The company operates through Sales, CDMO, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services and technical services for the development of pharmaceutical products. In addition, it provides Western pharmaceuticals, including central nervous system medications, antibioti... [Read more]

Sector Healthcare
Founded 2007
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 6472
Full Company Profile

Financial Performance

In 2024, Bora Pharmaceuticals's revenue was 19.25 billion, an increase of 35.53% compared to the previous year's 14.20 billion. Earnings were 3.94 billion, an increase of 29.99%.

Financial Statements